New Formulations: Sodium Cromoglycate
October 2004
in “
Australian Prescriber
”
Studysummary This review discusses the management of long-term risks in women with polycystic ovary syndrome, recommending lifestyle changes to improve insulin sensitivity over relying solely on metformin, and reports no new clinical results.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document discussed the management of hirsutism and the associated long-term risks, particularly focusing on insulin resistance and its link to metabolic syndrome and cardiovascular disease. It noted that while medications like flutamide and finasteride were not widely used in Australia due to potential side effects, there were no long-term clinical studies on the cardiovascular benefits of metformin for women with polycystic ovary syndrome. The findings from the Diabetes Prevention Program Research Group indicated that lifestyle changes were more effective than metformin in reducing the incidence of type 2 diabetes, suggesting that clinicians should focus on helping patients achieve lifestyle changes to reduce body mass and improve insulin sensitivity.
